Naloxone is an opioid antagonist, used as an "antidote" for opioid overdose which includes heroin, and opioid pain medicines such as morphine, fentanyl and codeine. It has been used since the 1970s by ambulance services and ...
Aug 31, 2016
0
0
Preventing or shortening the duration of migraine attacks – established drug treatment options and those that could shape future therapies were discussed at the Congress of European Academy of Neurology in Copenhagen.
Jun 1, 2016
0
2
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in ...
Aug 31, 2015
0
11
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus's entry into cells and halt the disease in its tracks, according to researchers at the University of ...
Aug 7, 2015
0
77
The SENRI trial has opened the window to evaluate NK1 antagonists for emesis prevention in patients taking oxaliplatin chemotherapy, antiemetics expert and ESMO spokesperson Fausto Roila said, putting into perspective the ...
Jul 1, 2015
0
3
Certain commonly prescribed anti-nausea medications given to patients during or after an operation could increase their risk of developing an irregular heartbeat, new research has found.
Jun 18, 2015
0
19
(Medical Xpress)—A team of scientists at the University of Manchester has now found a key to why and how infection is such a bad thing for stroke sufferers
Apr 15, 2014
0
0
Patients with the connective tissue disorder Loeys-Dietz syndrome (LDS) are at high risk for aortic aneurysm. LDS results in the presence of missense mutations within either of the genes encoding receptors for TGF-β. LDS-associated ...
Dec 20, 2013
0
0
Use for 2 or more years of proton pump inhibitors and histamine 2 receptor antagonists (two types of acid-inhibiting medications) was associated with a subsequent new diagnosis of vitamin B12 deficiency, according to a study ...
Dec 10, 2013
0
1
Two years ago, mammalian target of rapamycin or mTOR, a signaling protein, was identified as a key mediator of the antidepressant effects of ketamine, the first rapidly acting antidepressant medication to be identified.
Nov 19, 2013
0
1
